Aemetis (NASDAQ:AMTX) Stock Passes Below Two Hundred Day Moving Average – Here’s Why

Aemetis, Inc (NASDAQ:AMTXGet Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.29 and traded as low as $1.55. Aemetis shares last traded at $1.59, with a volume of 581,822 shares.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Ascendiant Capital Markets cut their price objective on shares of Aemetis from $21.00 to $20.00 and set a “buy” rating on the stock in a report on Wednesday, November 19th. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, October 8th. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Aemetis presently has an average rating of “Moderate Buy” and an average price target of $17.00.

View Our Latest Analysis on Aemetis

Aemetis Stock Down 2.5%

The stock has a 50-day moving average of $1.64 and a 200 day moving average of $2.29. The stock has a market cap of $105.26 million, a PE ratio of -0.99 and a beta of 2.31.

Aemetis (NASDAQ:AMTXGet Free Report) last posted its quarterly earnings results on Friday, November 7th. The specialty chemicals company reported ($0.37) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.12). The business had revenue of $59.19 million for the quarter, compared to the consensus estimate of $87.79 million. On average, equities analysts anticipate that Aemetis, Inc will post -2.07 EPS for the current year.

Institutional Investors Weigh In On Aemetis

Several hedge funds have recently added to or reduced their stakes in AMTX. Clear Harbor Asset Management LLC raised its stake in shares of Aemetis by 31.0% during the 2nd quarter. Clear Harbor Asset Management LLC now owns 21,950 shares of the specialty chemicals company’s stock valued at $54,000 after buying an additional 5,200 shares during the last quarter. Vanguard Personalized Indexing Management LLC grew its holdings in Aemetis by 48.7% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 19,611 shares of the specialty chemicals company’s stock worth $49,000 after acquiring an additional 6,420 shares during the period. Catalyst Funds Management Pty Ltd purchased a new position in Aemetis during the second quarter valued at approximately $25,000. R Squared Ltd acquired a new position in Aemetis in the second quarter valued at approximately $30,000. Finally, Creative Planning purchased a new stake in Aemetis in the 2nd quarter worth approximately $30,000. 27.02% of the stock is owned by hedge funds and other institutional investors.

About Aemetis

(Get Free Report)

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.

See Also

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.